Our researchers are working to develop new therapies to treat neuroblastoma and other complex pediatric tumors. Patients have the opportunity to be the first to benefit from these groundbreaking therapies.
Current studies include:
Metabolomics Study
This study is trying to understand if there are changes in the metabolism of neuroblastoma cells that make some tumors more likely to spread and recur.
Clinical Studies for Relapsed Disease
We offer many options for children with neuroblastoma that recurs or doesn’t respond to treatment. We participate in multiple consortiums to offer these clinical trials. Many of these trials are looking at targeting genetic mutations or genetic pathways that are thought to lead to development of neuroblastoma.
Learn more about these studies and see all neuroblastoma clinical trials at UT Southwestern.
